Literature DB >> 8381383

Human hepatic stimulator substance: a product of gene expression of human fetal liver tissue.

F He1, C Wu, Q Tu, G Xing.   

Abstract

Cloning of human hepatic stimulator substance requires clarification of whether the substance is the product of gene expression of liver cells. In this article the translation experiment in Xenopus laevis oocytes indicates that poly (A)+ messenger RNA of human fetal liver cells could conduct the biosynthesis of human hepatic stimulator substance. The translated human hepatic stimulator substance is a heat-, acid- and alkaline-resistant, but specific hepatic-stimulating, protein with a molecular weight in the range of 10 to 30 kD and with secreting ability. The characteristics of the translated human hepatic stimulator substance are consistent with those of biochemically purified human hepatic stimulator substance from human fetal liver cells. These results demonstrate that human hepatic stimulator substance is a product of gene expression of human fetal liver cells and that the complementary DNA of human hepatic stimulator substance could be screened from the complementary DNA library of human fetal liver tissue.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381383

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  13 in total

1.  Partial isolation and identification of hepatic stimulator substance mRNA extracted from human fetal liver.

Authors:  Xiao-Ming Yang; Ling Xie; Gui-Chun Xing; Zu-Ze Wu; Fu-Chu He
Journal:  World J Gastroenterol       Date:  1998-04       Impact factor: 5.742

2.  Cloning and sequence analysis of human genomic DNA of augmenter of liver regeneration.

Authors:  Jun Cheng; Yan-Wei Zhong; Yan Liu; Jing Dong; Ji-Zhen Yang; Ju-Mei Chen
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

Review 3.  Advances in gene therapy of liver cirrhosis: a review.

Authors:  W J Dai; H C Jiang
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

4.  Hepatic stimulator substance activity in animal model of fulminant hepatic failure and encephalopathy.

Authors:  Alexandra P Margeli; Evangelos Manolis; Spyridon N Skaltsas; Kyriakos S Tsarpalis; Michael G Mykoniatis; Stamatios E Theocharis
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

5.  Hepatic stimulator substance alleviates toxin-induced and immune-mediated liver injury and fibrosis in rats.

Authors:  Xuerui Yi; Ming Song; Youcheng Yuan; Xinrui Zhang; Wenyin Chen; Jin Li; Minghua Tong; Guangze Liu; Song You; Xiangping Kong
Journal:  Dig Dis Sci       Date:  2012-04-27       Impact factor: 3.199

6.  Increased hepatic apoptosis in high-fat diet-induced NASH in rats may be associated with downregulation of hepatic stimulator substance.

Authors:  Ying Jiang; Miaoyun Zhao; Wei An
Journal:  J Mol Med (Berl)       Date:  2011-08-04       Impact factor: 4.599

7.  Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family.

Authors:  Xianghu Qu; Yun Zhai; Handong Wei; Chenggang Zhang; Guichun Xing; Yongtao Yu; Fuchu He
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

8.  Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution.

Authors:  M Hagiya; A Francavilla; L Polimeno; I Ihara; H Sakai; T Seki; M Shimonishi; K A Porter; T E Starzl
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

9.  Adenoviral gene transfer of hepatic stimulator substance confers resistance against hepatic ischemia-reperfusion injury by improving mitochondrial function.

Authors:  Shu-Jun Jiang; Wen Li; Wei An
Journal:  Hum Gene Ther       Date:  2013-04       Impact factor: 5.695

10.  Involvement of hepatic stimulator substance in the regulation of hepatoblast maturation into hepatocytes in vitro.

Authors:  Guang-Yong Sun; Ling-Yue Dong; Wei An
Journal:  Stem Cells Dev       Date:  2014-05-02       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.